Our scientific journey in CVRM is revealing a paradigm shift in how we view these diseases. No longer isolated conditions, we now see a network of interrelated factors influencing cardiovascular, renal, and metabolic health.
Mina Makar Senior Vice President, Global Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals Business Unit
We have
191
projects in our pipeline
Corporate Press Release
Corporate Press Release